MedTrace Logo

Association of Carbamylated HDL and CAD in T2DM Patients

NCT04390711 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 282

Last updated 2020-05-18

No results posted yet for this study

Summary

This is an observational cross-sectional study aimed at investigating the alterations of the carbamylated-HDL levels in T2DM patients, and comparing the concentration of carbamylated-HDL between the T2DM patients with CAD and without CAD to explore the association between carbamylated-HDL and risk of CAD in T2DM patients.

Conditions

  • Type 2 Diabetes Mellitus With Circulatory Complciation

Interventions

OTHER

High density lipoprotein isolation, detection and in-vitro study.

All blood samples were taken on the day of cardiac catheterization after overnight fasting.High density lipoprotein from each participants was isolated and further collected for carbamylation level detection and in-vitro study.

Sponsors & Collaborators

  • Ruijin Hospital

    collaborator OTHER

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Song Ding, MD · Department of Cardiology, Ren Ji Hospital

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2019-03-30
Completion
2019-03-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04390711 on ClinicalTrials.gov